drs. W.C.M. de Lange

E-mail:
w.c.m.de.lange umcg.nl

Research

  1. 2019
  2. 2018
  3. 2017
  4. Magis-Escurra, C., Guenther, G., Lange, C., Alexandru, S., Altet, N., Avsar, K., ... TBnet (2017). Treatment outcomes of MDR-TB and HIV co-infection in Europe. European Respiratory Journal, 49(6), [1602363]. https://doi.org/10.1183/13993003.02363-2016
  5. Hofland, R. W., Thijsen, S. F. T., van Lindert, A. S. R., de Lange, W. C. M., van Gorkom, T., van der Tweel, I., ... Bossink, A. W. J. (2017). Positive predictive value of ELISpot in BAL and pleural fluid from patients with suspected pulmonary tuberculosis. ACS Infectious Diseases, 49(5), 347-355. https://doi.org/10.1080/23744235.2016.1269190
  6. 2016
  7. Guenther, G., Lange, C., Alexandru, S., Altet, N., Avsar, K., Bang, D., ... van Leth, F. (2016). Treatment Outcomes in Multidrug-Resistant Tuberculosis. New England Journal of Medicine, 375(11), 1103-1105. https://doi.org/10.1056/NEJMc1603274
  8. 2015
  9. Guenther, G., van Leth, F., Alexandru, S., Altet, N., Avsar, K., Bang, D., ... TBnet (2015). Multidrug-Resistant Tuberculosis in Europe, 2010-2011. Emerging Infectious Diseases, 21(3), 409-416. https://doi.org/10.3201/eid2103.141343
  10. 2014
  11. 2013
  12. 2012
  13. Ahuja, S. D., Ashkin, D., Avendano, M., Banerjee, R., Bauer, M., Bayona, J. N., ... Collaborative Grp Meta-Anal (2012). Multidrug Resistant Pulmonary Tuberculosis Treatment Regimens and Patient Outcomes: An Individual Patient Data Meta-analysis of 9,153 Patients. PLOS MEDICINE, 9(8), [e1001300]. https://doi.org/10.1371/journal.pmed.1001300
Previous 1 2 Next

ID: 409966